Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie)
Refine
Has Fulltext
- yes (74)
Is part of the Bibliography
- yes (74)
Year of publication
Document Type
- Journal article (68)
- Doctoral Thesis (6)
Keywords
- ischemic stroke (6)
- mechanical thrombectomy (4)
- chemotherapy (3)
- cochlear implantation (3)
- neutrophils (3)
- thrombo-inflammation (3)
- 3D fluoroscopy (2)
- Childhood medulloblastoma (2)
- Clinical Neuroradiology (2)
- Kernspintomografie (2)
Institute
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (74)
- Neurologische Klinik und Poliklinik (26)
- Physikalisches Institut (8)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (7)
- Institut für Experimentelle Biomedizin (6)
- Medizinische Klinik und Poliklinik I (6)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (5)
- Rudolf-Virchow-Zentrum (5)
- Medizinische Klinik und Poliklinik II (4)
- Neurochirurgische Klinik und Poliklinik (4)
Sonstige beteiligte Institutionen
Context:
Hypothalamic obesity, cardiovascular disease (CVD), and relapse/progression have a major impact on prognosis in childhood-onset craniopharyngioma (CP). We analyzed nuchal skinfold thickness (NST) on magnetic resonance imaging performed for follow-up monitoring as a novel parameter for body composition (BC) and CVD in CP.
Objective:
The objective of the study was to identify the association of NST with body mass index (BMI), waist to height ratio (WHtR), functional capacity, and blood pressure (BP) in CP and controls.
Design:
This was a cross-sectional and longitudinal prospective study in CP patients. Setting: The study was conducted at HIT-Endo, KRANIOPHARYNGEOM 2000/2007.
Patients:
Participants included 94 CP patients and 75 controls.
Interventions:
There were no interventions.
Main Outcome Measures:
Association of NST with BC and BP in 43 CP and 43 controls was measured.
Results:
NST correlated with BMI SD score (SDS; r = 0.78; P = .001; n = 169) and WHtR (r = 0.85; P = .001; n = 86) in the total cohort and CP patients (NST-BMI SDS: r = 0.77, P = .001, n = 94); NST-WHtR: r = 0.835, P = .001, n = 43) and controls (NST-BMI SDS: r = 0.792, P = .001, n = 75; NST-WHtR: r = 0.671, P = .001, n = 43). In CP, systolic BP correlated with NST (r = 0.575, P = .001), BMI SDS (r = 0.434, P = .004), and WHtR (r = 0.386, P = .011). Similar results were observed for diastolic BP in CP. In multivariate analyses, NST had a predictive value for hypertension in postpubertal CP and controls (odds ratio 6.98, 95% confidence interval 1.65, 29.5], P = .008). During a longitudinal follow-up, changes in NST correlated with changes in BMI SDS (P = .001) and WHtR (P = .01) but not with changes in BP and functional capacity.
Conclusions:
Because monitoring of magnetic resonance imaging and BC is essential for follow-up in CP, NST could serve as a novel and clinically relevant parameter for longitudinal assessment of BC and CVD risk in CP.
Platelet collagen interactions at sites of vascular injuries predominantly involve glycoprotein VI (GPVI) and the integrin α2β1. Both proteins are primarily expressed on platelets and megakaryocytes whereas GPVI expression is also shown on endothelial and integrin α2β1 expression on epithelial cells. We recently showed that depletion of GPVI improves stroke outcome without increasing the risk of cerebral hemorrhage. Genetic variants associated with higher platelet surface integrin α2 (ITGA2) receptor levels have frequently been found to correlate with an increased risk of ischemic stroke in patients. However until now, no preclinical stroke study has addressed whether platelet integrin α2β1 contributes to the pathophysiology of ischemia/reperfusion (I/R) injury. Focal cerebral ischemia was induced in C57BL/6 and Itga2\(^{−/−}\) mice by a 60 min transient middle cerebral artery occlusion (tMCAO). Additionally, wild-type animals were pretreated with anti-GPVI antibody (JAQ1) or Fab fragments of a function blocking antibody against integrin α2β1 (LEN/B). In anti-GPVI treated animals, intravenous (IV) recombinant tissue plasminogen activator (rt-PA) treatment was applied immediately prior to reperfusion. Stroke outcome, including infarct size and neurological scoring was determined on day 1 after tMCAO. We demonstrate that targeting the integrin α2β1 (pharmacologic; genetic) did neither reduce stroke size nor improve functional outcome on day 1 after tMCAO. In contrast, depletion of platelet GPVI prior to stroke was safe and effective, even when combined with rt-PA treatment. Our results underscore that GPVI, but not ITGA2, is a promising and safe target in the setting of ischemic stroke.
Background and Purpose: Internal carotid artery stenosis (ICAS)≥70% is a leading cause of ischemic cerebrovascular events (ICVEs). However, a considerable percentage of stroke survivors with symptomatic ICAS (sICAS) have <70% stenosis with a vulnerable plaque. Whether the length of ICAS is associated with high risk of ICVEs is poorly investigated. Our main aim was to investigate the relation between the length of ICAS and the development of ICVEs.
Methods: In a retrospective cross-sectional study, we identified 95 arteries with sICAS and another 64 with asymptomatic internal carotid artery stenosis (aICAS) among 121 patients with ICVEs. The degree and length of ICAS as well as plaque echolucency were assessed on ultrasound scans.
Results: A statistically significant inverse correlation between the ultrasound-measured length and degree of ICAS was detected for sICAS≥70% (Spearman correlation coefficient ρ = –0.57, p < 0.001, n = 51) but neither for sICAS<70% (ρ = 0.15, p = 0.45, n = 27) nor for aICAS (ρ = 0.07, p = 0.64, n = 54). The median (IQR) length for sICAS<70% and ≥70% was 17 (15–20) and 15 (12–19) mm (p = 0.06), respectively, while that for sICAS<90% and sICAS 90% was 18 (15–21) and 13 (10–16) mm, respectively (p < 0.001). Among patients with ICAS <70%, a cut-off length of ≥16 mm was found for sICAS rather than aICAS with a sensitivity and specificity of 74.1% and 51.1%, respectively. Irrespective of the stenotic degree, plaques of the sICAS compared to aICAS were significantly more often echolucent (43.2 vs. 24.6%, p = 0.02).
Conclusion: We found a statistically insignificant tendency for the ultrasound-measured length of sICAS<70% to be longer than that of sICAS≥70%. Moreover, the ultrasound-measured length of sICAS<90% was significantly longer than that of sICAS 90%. Among patients with sICAS≥70%, the degree and length of stenosis were inversely correlated. Larger studies are needed before a clinical implication can be drawn from these results.
Background: Cervical dystonia is a movement disorder causing abnormal postures and movements of the head. While the exact pathophysiology of cervical dystonia has not yet been fully elucidated, a growing body of evidence points to the cerebellum as an important node.
Methods: Here, we examined the impact of cerebellar interference by transcranial magnetic stimulation on finger-tapping related brain activation and neurophysiological measures of cortical excitability and inhibition in cervical dystonia and controls. Bilateral continuous theta-burst stimulation was used to modulate cerebellar cortical excitability in 16 patients and matched healthy controls. In a functional magnetic resonance imaging arm, data were acquired during simple finger tapping before and after cerebellar stimulation. In a neurophysiological arm, assessment comprised motor-evoked potentials amplitude and cortical silent period duration. Theta-burst stimulation over the dorsal premotor cortex and sham stimulation (neurophysiological arm only) served as control conditions.
Results: At baseline, finger tapping was associated with increased activation in the ipsilateral cerebellum in patients compared to controls. Following cerebellar theta-burst stimulation, this pattern was even more pronounced, along with an additional movement-related activation in the contralateral somatosensory region and angular gyrus. Baseline motor-evoked potential amplitudes were higher and cortical silent period duration shorter in patients compared to controls. After cerebellar theta-burst stimulation, cortical silent period duration increased significantly in dystonia patients.
Conclusion: We conclude that in cervical dystonia, finger movements—though clinically non-dystonic—are associated with increased activation of the lateral cerebellum, possibly pointing to general motor disorganization, which remains subclinical in most body regions. Enhancement of this activation together with an increase of silent period duration by cerebellar continuous theta-burst stimulation may indicate predominant disinhibitory effects on Purkinje cells, eventually resulting in an inhibition of cerebello-thalamocortical circuits.
Atypical teratoid rhabdoid tumors (AT/RT) are characterized by mutations and subsequent inactivation of SMARCB1 (INI1, hSNF5), a predilection for very young children and an unfavorable outcome. The European Registry for rhabdoid tumors (EU‐RHAB) was established to generate a common European database and to establish a standardized treatment regimen as the basis for phase I/II trials. Thus, genetic analyses, neuropathologic and radiologic diagnoses, and a consensus treatment regimen were prospectively evaluated. From 2005 to 2009, 31 patients with AT/RT from four countries were recruited into the registry study Rhabdoid 2007 and treated with systemic and intraventricular chemotherapy. Eight patients received high‐dose chemotherapy, 23 radiotherapy, and 17 maintenance therapy. Reference evaluations were performed in 64% (genetic analyses, FISH, MLPA, sequencing) up to 97% (neuropathology, INI1 stain). Germ‐line mutations (GLM) were detected in 6/21 patients. Prolonged overall survival was associated with age above 3 years, radiotherapy and achievement of a complete remission. 6‐year overall and event‐free survival rates were 46% (±0.10) and 45% (±0.09), respectively. Serious adverse events and one treatment‐related death due to insufficiency of a ventriculo peritoneal shunt (VP‐shunt) and consecutive herniation were noted. Acquisition of standardized data including reference diagnosis and a standard treatment schedule improved data quality along with a survival benefit. Treatment was feasible with significant but manageable toxicity. Although our analysis is biased due to heterogeneous adherence to therapy, EU‐RHAB provides the best available basis for phase I/II clinical trials.
Bei Patienten mit hochgradigem sensorineuralem Hörverlust, der nicht mehr ausreichend mittels Hörgeräten kompensiert werden kann, hat sich die CI-Versorgung zur Verbesserung der Hörfähigkeit als Standardmethode etabliert und ihr Indikationsbereich wächst. Zur Beurteilung des auditorischen Systems sowie seiner angrenzenden Nachbarstrukturen zählt die neuroradiologische Diagnostik mittels spezieller CT- und MRT-Techniken zu den entscheidenden Kriterien zur CI-Indikationsstellung und der Operationsplanung. In der Literatur finden sich verschiedenste Meinungen zur Bedeutung dieser präoperativen Bildgebungen vor Cochlea-Implantationen und die Wahl einer CT- und bzw. oder einer MRT-Untersuchung zur präoperativen Diagnostik wird diskutiert. So wurden am Universitätsklinikum Würzburg im Zeitraum von 2005 bis zum Jahr 2015 zur Diagnostik vor der CI-Operation eines Patienten meist sowohl eine CT-Aufnahme des Felsenbeins als auch eine MRT-Aufnahme des Schädels angefertigt. Im Rahmen dieser Arbeit sollte untersucht werden, inwieweit diese beiden präoperativen CT- und MRT-Untersuchungen für die CI-Operation und die Ursachenabklärung der Hörminderung von Relevanz waren und ob eine Empfehlung für die zukünftige Wahl der Diagnostikmethoden abgegeben werden kann. Dazu wurden Anamnesen, Voruntersuchungen, präoperative CT- und MRT-Bildgebungen und die Operationsberichte von 705 CI-Fällen bei 549 Patienten, die in diesem Zeitraum operiert wurden, retrospektiv ausgewertet. Die Darstellbarkeiten verschiedener Pathologien, die mit Hilfe der beiden Bildgebungsverfahren detektiert wurden, wurden miteinander verglichen und es wurde überprüft, ob ein Verfahren möglicherweise besser zur Diagnostik bestimmter Auffälligkeiten geeignet war als das andere. Durch die Auswertung der Operationsberichte wurde evaluiert, ob und wie die Befunde der präoperativen Bildgebungen mit den intraoperativen Situationen übereinstimmten und ob diese Befunde die Operationsplanung beeinflusst hatten.
Die Ergebnisse dieser Arbeit zeigten, dass die bildgebenden Verfahren zur Ursachenfindung einer nicht abgeklärten Hörminderung beitragen können. Des Weiteren konnte gefolgert werden, dass ein Großteil von Auffälligkeiten im Bereich des Felsenbeins, die mit sensorineuralen Schwerhörigkeiten assoziiert sind, mit hoher Wahrscheinlichkeit sowohl mittels CT- als auch mittels MRT-Untersuchung diagnostiziert werden kann. Für einzelne Läsionen konnte vermutet werden, dass diese nur durch die CT und umgekehrt bestimmte Läsionen nur durch die MRT detektiert werden können. Außerdem zeigte sich, dass die beiden bildgebenden Verfahren auf bestimmte Schwierigkeiten, die während einer CI-Operation auftreten können, präoperativ hinweisen können. Zusätzlich konnte festgestellt werden, dass die Wahl der Implantations-Seite bei einseitig operierten aber beidseits schwerhörigen Patienten neben den CT- und MRT-Untersuchungen in den meisten Fällen von weiteren Faktoren abhing.
Aus den Ergebnissen dieser Arbeit konnte gefolgert werden, dass die Durchführung einer präoperativen CT- und einer MRT-Untersuchung die umfangreichste radiologische Diagnostikmethode ist, um eine CI-Operation zu planen, möglichst alle Auffälligkeiten, die zu Schwierigkeiten in der Operation führen können, zu detektieren und Ursachen für eine nicht abgeklärte Hörminderung zu finden. Dennoch sollte, insbesondere unter Berücksichtigung der Strahlenbelastung, die ein Patient im Rahmen eines Felsenbein-CTs erfährt, die Überlegung zugelassen werden, ob zukünftig nur die Durchführung einer MRT-Untersuchung als routinemäßiges Diagnostikverfahren ausreichen könnte. Eine zusätzliche CT-Untersuchung wäre dann nur unter bestimmten Voraussetzungen (z. B. Traumaanamnese des Schädels oder Hinweise auf ein Cholesteatom) indiziert. Weitere Untersuchungen, die zeigen, welche genauen Kriterien dazu seitens des Patienten gegeben sein müssten, sowie Langzeitergebnisse nach erfolgreichen CI-Operationen sollten Gegenstand weiterer Studien sein.
Objective: To investigate the association between levodopa‐induced dyskinesias and striatal cholinergic activity in patients with Parkinson's disease.
Methods: This study included 13 Parkinson's disease patients with peak‐of‐dose levodopa‐induced dyskinesias, 12 nondyskinetic patients, and 12 healthy controls. Participants underwent 5‐[\(^{123}\)I]iodo‐3‐[2(S)‐2‐azetidinylmethoxy]pyridine single‐photon emission computed tomography, a marker of nicotinic acetylcholine receptors, [\(^{123}\)I]N‐ω‐fluoropropyl‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)nortropane single‐photon emission computed tomography, to measure dopamine reuptake transporter density and 2‐[\(^{18}\)F]fluoro‐2‐deoxyglucose positron emission tomography to assess regional cerebral metabolic activity. Striatal binding potentials, uptake values at basal ganglia structures, and correlations with clinical variables were analyzed.
Results: Density of nicotinic acetylcholine receptors in the caudate nucleus of dyskinetic subjects was similar to that of healthy controls and significantly higher to that of nondyskinetic patients, in particular, contralaterally to the clinically most affected side.
Interpretation: Our findings support the hypothesis that the expression of dyskinesia may be related to cholinergic neuronal excitability in a dopaminergic‐depleted striatum. Cholinergic signaling would play a role in maintaining striatal dopaminergic responsiveness, possibly defining disease phenotype and progression.
Serotonergic modulation of 'waiting impulsivity' is mediated by the impulsivity phenotype in humans
(2016)
In rodents, the five-choice serial reaction time task (5-CSRTT) has been established as a reliable measure of waiting impulsivity being defined as the ability to regulate a response in anticipation of reinforcement. Key brain structures are the nucleus accumbens (NAcc) and prefrontal regions (for example, pre- and infralimbic cortex), which are, together with other transmitters, modulated by serotonin. In this functional magnetic resonance imaging study, we examined 103 healthy males while performing the 5-CSRTT measuring brain activation in humans by means of a paradigm that has been widely applied in rodents. Subjects were genotyped for the tryptophan hydroxylase-2 (TPH2; G-703T; rs4570625) variant, an enzyme specific for brain serotonin synthesis. We addressed neural activation patterns of waiting impulsivity and the interaction between the NAcc and the ventromedial prefrontal cortex (vmPFC) using dynamic causal modeling. Genetic influence was examined via interaction analyses between the TPH2 genotype (GG homozygotes vs T allele carriers) and the degree of impulsivity as measured by the 5-CSRTT. We found that the driving input of the vmPFC was reduced in highly impulsive T allele carriers (reflecting a reduced top-down control) in combination with an enhanced response in the NAcc after correct target processing (reflecting an augmented response to monetary reward). Taken together, we found a high overlap of our findings with reports from animal studies in regard to the underlying cognitive processes, the brain regions associated with waiting impulsivity and the neural interplay between the NAcc and vmPFC. Therefore, we conclude that the 5-CSRTT is a promising tool for translational studies.
Ziel der Arbeit war der Vergleich von zwei Druckverbandsystemen in Hinblick auf effektive Blutstillung, Patienten- sowie Anwenderfreundlichkeit. Dazu wurden 117 Patienten, die sich zwischen März 2011 und Dezember 2012 im Klinikum Fulda einer diagnostischen Angiographie unterzogen, in einer randomisierten offenen klinisch kontrollierten Studie untersucht.
Die in der Studie untersuchten Druckverbände stellten sich als gleich sicher und effektiv bei der Blutstillung heraus. Es traten in der gesamten Studienpopulation keine schwergradigen Komplikationen auf. Der Safeguard-Druckverband lässt sich leichter und schneller anbringen und entfernen, als der mit elastischen Binden fixierte ET-Druckverband. Er wurde zudem durch die Patienten besser toleriert und als bequemer empfunden.
Zusammenfassend ist der Safeguard-Druckverband nach unkomplizierten diagnostischen Angiographien ebenso sicher, wie der UFO-Druckverband und zeigte darüber hinaus eine höhere Anwender- und Patientenfreundlichkeit.
Background:
To study whether and how c-MYC expression determines response to radio-and chemotherapy in childhood medulloblastoma (MB).
Methods:
We used DAOY and UW228 human MB cells engineered to stably express different levels of c-MYC, and tested whether c-MYC expression has an effect on radio-and chemosensitivity using the colorimetric 3-(4,5-dimethylthiazol- 2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS) assay, clonogenic survival, apoptosis assays, cell cycle analysis, and western blot assessment. In an effort to validate our results, we analyzed c-MYC mRNA expression in formalin-fixed paraffin-embedded tumor samples from well-documented patients with postoperative residual tumor and compared c-MYC mRNA expression with response to radio-and chemotherapy as examined by neuroradiological imaging.
Results:
In DAOY -and to a lesser extent in UW228 -cells expressing high levels of c-MYC, the cytotoxicity of cisplatin, and etoposide was significantly higher when compared with DAOY/UW228 cells expressing low levels of c-MYC. Irradiation-and chemotherapy-induced apoptotic cell death was enhanced in DAOY cells expressing high levels of c-MYC. The response of 62 of 66 residual tumors was evaluable and response to postoperative radio-(14 responders (CR, PR) vs. 5 non-responders (SD, PD)) or chemotherapy (23 CR/PR vs. 20 SD/PD) was assessed. c-MYC mRNA expression was similar in primary MB samples of responders and non-responders (Mann-Whitney U test, p = 0.50, ratio 0.49, 95% CI 0.008-30.0 and p = 0.67, ratio 1.8, 95% CI 0.14-23.5, respectively).
Conclusions:
c-MYC sensitizes MB cells to some anti-cancer treatments in vitro. As we failed to show evidence for such an effect on postoperative residual tumors when analyzed by imaging, additional investigations in xenografts and larger MB cohorts may help to define the exact function of c-MYC in modulating response to treatment.